Special | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | ALL
Practical Assessment of Clinical Examination Skills (PACES) is an exam designed to test the clinical knowledge and skills of trainee doctors who hope to enter higher specialty training.
View all Paediatrics content
Pulmonary arterial hypertension (PAH) is a rare, progressive disorder characterised by high blood pressure in the arteries of the lungs, due to thickening and stiffening of the walls of the smaller branches of the pulmonary arteries. Over time, PAH damages the heart, which has to work harder to overcome this arterial resistance.
PAH can be associated with a number of conditions, including connective tissue diseases (such as scleroderma), portal hypertension, HIV, and certain medications/drugs. The cause may be unknown (idiopathic PAH).
View all Palliative Care content
View all Parkinson’s Disease content
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are a new type of cholesterol-lowering drug.
Parkinson's disease (PD) is a chronic, progressive neurodegenerative condition caused by lack of dopamine in the brain, due to loss of the dopamine-containing cells of the substantia nigra.
PD is a movement disorder with four core features: tremor (shaking), bradykinesia (slowness of movement), rigidity (muscle stiffness) and postural instability (difficulty with balance and coordination).
Pulmonary embolism/emboli (PE) occurs when a blood vessel in the lung(s) is blocked by a blood clot.